loading...
loading...
loading...

Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech

https://ift.tt/eA8V8J
https://www.ndtv.com
Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among...

from NDTV News - Topstories https://ift.tt/3HTxies
via IFTTT

Post a Comment

[blogger]

Author Name

Contact Form

Name

Email *

Message *

Powered by Blogger.